U.S. FDA Grants Orphan Drug Designation to ANAVEX 3-71 for the Treatment of Frontotemporal Dementia GlobeNewswire
Initated long as price moved to near high of day.
Exited as price hit stop loss.
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2016-04-08 10:47:53 | AVXL | buy | $6.190 | long |
2016-04-08 10:59:00 | AVXL | sell | $6.050 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!